Tuberc Respir Dis.  2020 Apr;83(2):147-156. 10.4046/trd.2019.0073.

Reasons and Risk Factors for Readmission Following Hospitalization for Community-acquired Pneumonia in South Korea

Affiliations
  • 1Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea. fireajh@gmail.com

Abstract

BACKGROUND
Limited studies have been performed to assess readmission following hospitalization for community-acquired pneumonia (CAP) in an Asian population. We evaluated the rates, reasons, and risk factors for 30-day readmission following hospitalization for CAP in the general adult population of Korea.
METHODS
We performed a retrospective observational study of 1,021 patients with CAP hospitalized at Yeungnam University from March 2012 to February 2014. The primary end point was all-cause hospital readmission within 30 days following discharge after the initial hospitalization. Hospital readmission was classified as pneumonia-related or pneumonia-unrelated readmission.
RESULTS
During the study period, 862 patients who survived to hospital discharge were eligible for inclusion and among them 72 (8.4%) were rehospitalized within 30 days. In the multivariable analysis, pneumonia-related readmission was associated with para/hemiplegia, malignancy, pneumonia severity index class ≥4 and clinical instability ≥1 at hospital discharge. Comorbidities such as chronic lung disease and chronic kidney disease, treatment failure, and decompensation of comorbidities were associated with the pneumonia-unrelated 30-day readmission rate.
CONCLUSION
Rehospitalizations within 30 days following discharge were frequent among patients with CAP. The risk factors for pneumonia-related and -unrelated readmission were different. Aspiration prevention, discharge at the optimal time, and close monitoring of comorbidities may reduce the frequency of readmission among patients with CAP.

Keyword

Risk Factors; Pneumonia; Koreans; Hospital Readmission; Causes

MeSH Terms

Adult
Asian Continental Ancestry Group
Comorbidity
Hospitalization*
Humans
Korea*
Lung Diseases
Observational Study
Patient Readmission
Pneumonia*
Renal Insufficiency, Chronic
Retrospective Studies
Risk Factors*
Treatment Failure

Figure

  • Figure 1 Study design: 1,021 index hospitalizations for community-acquired pneumonia were identified. After excluding patients who died during the index hospitalization, those who discharged themselves against medical advice and refused outpatient follow-up, and those transferred to another acute care facility, the final cohort comprised 862 patients.

  • Figure 2 Readmission rate according to number of risk factors.


Cited by  2 articles

Development of a Transitional Care Model Program for Patients with Pneumonia, Asthma, and Chronic Obstructive Pulmonary Disease: In-depth Interviews with Readmitted Patients
Heui Sug Jo, Seungmin Jeong, Woo Jin Kim, Seolhyang Park, Seol Ae Yu
J Korean Med Sci. 2020;35(42):e352.    doi: 10.3346/jkms.2020.35.e352.

Continuing Quality Assessment Program Improves Clinical Outcomes of Hospitalized Community-Acquired Pneumonia: A Nationwide Cross-Sectional Study in Korea
Tai Joon An, Jun-Pyo Myong, Yun-Hee Lee, Sang Ok Kwon, Eun Kyung Shim, Ji Hyeon Shin, Hyoung Kyu Yoon, Sung Hwan Jeong
J Korean Med Sci. 2022;37(30):e234.    doi: 10.3346/jkms.2022.37.e234.


Reference

1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2:S27–S72. PMID: 17278083.
Article
2. Shin HY, Lee JY, Song J, Lee S, Lee J, Lim B, et al. Cause-of-death statistics in the Republic of Korea, 2014. J Korean Med Assoc. 2016; 59:221–232.
Article
3. Choi MJ, Song JY, Noh JY, Yoon JG, Lee SN, Heo JY, et al. Disease burden of hospitalized community-acquired pneumonia in South Korea: analysis based on age and underlying medical conditions. Medicine (Baltimore). 2017; 96:e8429. PMID: 29095281.
4. Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013; 309:355–363. PMID: 23340637.
Article
5. Dharmarajan K, Wang Y, Lin Z, Normand ST, Ross JS, Horwitz LI, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. 2017; 318:270–278. PMID: 28719692.
Article
6. Lee JE, Kim TH, Cho KH, Han KT, Park EC. The association between number of doctors per bed and readmission of elderly patients with pneumonia in South Korea. BMC Health Serv Res. 2017; 17:393. PMID: 28595583.
Article
7. De Alba I, Amin A. Pneumonia readmissions: risk factors and implications. Ochsner J. 2014; 14:649–654. PMID: 25598730.
8. Ahn JH, Choi EY. Expanded A-DROP score: a new scoring system for the prediction of mortality in hospitalized patients with community-acquired pneumonia. Sci Rep. 2018; 8:14588. PMID: 30275523.
Article
9. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr. Assessing illness severity: does clinical judgment work? J Chronic Dis. 1986; 39:439–452. PMID: 3086355.
Article
10. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336:243–250. PMID: 8995086.
Article
11. Lim WS, van der, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58:377–382. PMID: 12728155.
Article
12. Yandiola PPE, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest. 2009; 135:1572–1579. PMID: 19141524.
Article
13. Capelastegui A, Espana Yandiola PP, Quintana JM, Bilbao A, Diez R, Pascual S, et al. Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia. Chest. 2009; 136:1079–1085. PMID: 19395580.
Article
14. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279:1452–1457. PMID: 9600479.
15. Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis. 2008; 46:550–556. PMID: 18194099.
Article
16. Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, et al. Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis. 2013; 57:362–367. PMID: 23677872.
Article
17. Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, Siu AL. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med. 2002; 162:1278–1284. PMID: 12038946.
Article
18. Adamuz J, Viasus D, Camprecios-Rodriguez P, Canavate-Jurado O, Jimenez-Martinez E, Isla P, et al. A prospective cohort study of healthcare visits and rehospitalizations after discharge of patients with community-acquired pneumonia. Respirology. 2011; 16:1119–1126. PMID: 21736665.
Article
19. Prescott HC, Sjoding MW, Iwashyna TJ. Diagnoses of early and late readmissions after hospitalization for pneumonia: a systematic review. Ann Am Thorac Soc. 2014; 11:1091–1100. PMID: 25079245.
Article
20. Komiya K, Rubin BK, Kadota JI, Mukae H, Akaba T, Moro H, et al. Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: a systematic review with meta-analysis. Sci Rep. 2016; 6:38097. PMID: 27924871.
Article
21. Harada J, Sekizawa K. Angiotensin-converting enzyme inhibitors and pneumonia in elderly patients with intracerebral hemorrhage. J Am Geriatr Soc. 2006; 54:175–176. PMID: 16420224.
Article
22. Caldeira D, Alarcao J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ. 2012; 345:e4260. PMID: 22786934.
Article
23. Luk JK, Chan DK. Preventing aspiration pneumonia in older people: do we have the ‘know-how’? Hong Kong Med J. 2014; 20:421–427. PMID: 24993858.
Article
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr